(Reuters) - Sunesis Pharmaceuticals Inc said its experimental cancer drug did not meet the main goal in a late-stage trial, sending the company's shares plunging 77 percent to their lowest in more than two years.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment